线素激活蛋白激酶和探索性核受体交叉在癌症免疫治疗中的交叉
1Department of Medicine II, Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, D-68167 Mannheim, Germany.
International journal of molecular sciences
|October 14, 2023
概括
线素激活蛋白激酶通路调节核受体 (NRSF),这些受体感知环境线索. 癌症和免疫细胞中的NRSF子类为免疫检查点抑制剂的新型组合疗法提供了潜力.
科学领域:
- 分子生物学分子生物学
- 癌症生物学 癌症生物学
- 免疫学 免疫学 免疫学
背景情况:
- 核受体激活蛋白激酶 (MAPK) 途径 (ERK1/2,p38,JNK/SAPK) 是核受体超级家族 (NRSF) 的关键调节者.
- NRSF是连接体激活的转录因子,可感知各种信号,如荷尔蒙,代谢物,异生菌和免疫媒介.
- NRSF作为关键传感器,将环境信息转化为基因组,许多以前的"孤儿"受体现在已经确定了连接体.
研究的目的:
- 审查NRSF子类在人类固体瘤和血液形成性恶性瘤中的表达和功能.
- 探索NRSF对先天和适应性免疫细胞的调节作用.
- 突出涉及NRSF和现有癌症治疗的组合疗法的机会.
主要方法:
- 关于癌症和免疫中的NRSF现有研究的文献综述.
- 在各种癌症类型中分析NRSF表达和功能.
- 检查NRSF与免疫细胞的相互作用,包括巨细胞,树突细胞和T细胞子集.
主要成果:
- 在固体瘤和血液形成性恶性瘤中表达NRSF子类.
- NRSF影响先天性免疫细胞 (巨细胞,树突细胞) 和适应性免疫细胞 (T细胞子集) 的功能.
- 临床前数据表明NRSF向治疗的潜力,特别是与PD1等免疫检查点抑制剂结合使用.
结论:
- 在癌症生物学和免疫调节方面,NRSF发挥着重要作用.
- 对NRSF的配体的识别为治疗干预开辟了道路.
- 针对NRSF和癌症治疗中的免疫检查点的组合疗法需要进一步的临床验证.
相关概念视频
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
MAPK Signaling Cascades
5.6K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.6K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Signal Transduction: Overview
8.6K
Cells respond to many types of information, often through receptor proteins positioned on the membrane. They respond to chemical signals, such as hormones, neurotransmitters, and other signaling molecules, initiating a series of molecular reactions to produce an appropriate response. This is called signal transduction. Cells also coordinate different responses elicited by the same signaling molecule via mediators, allowing molecular cross-talk.
Typically, signal transduction involves three...
Typically, signal transduction involves three...
8.6K
The JAK-STAT Signaling Pathway
8.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.9K


